Director sold ~$105K of Krystal Biotech
Scheduled in advanceLoading…
Traded Feb 19, 2026 · Filed Feb 24, 2026
A board member of Krystal Biotech sold $2.84M of Krystal Biotech shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,839,591
Shares × reported transaction price
2 days after results of Feb 17, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.2% | −1.0% | −0.1% |
| 30 days | −5.8% | −6.2% | +0.3% |
| 90 days | +13.4% | +9.2% | +4.2% |
| 180 days | +28.0% | +11.1% | +17.0% |
Past results only. Not a forecast.
Director sold ~$105K of Krystal Biotech
Scheduled in advanceDirector sold ~$152K of Krystal Biotech
Automatic saleDirector sold ~$173K of Krystal Biotech
Automatic sale